Chief Scientific Officer at OracleBio Ltd., providers of high quality, precision histopathology image analysis quantification services to support pre-clinical and clinical Pharmaceutical R&D studies and companion diagnostics development. Our services deliver reproducible, informed data permitting meaningful interpretation of the therapeutic mechanism of action of drugs in tissues allowing for improved decision making within R&D.Specialties: Highly experienced in providing image analysis services for quantification of drug response read-outs and biomarker expression within brightfield and fluorescent stained histology / IHC tissue slides. Expertise in use of Visiopharm Oncotopix and Indica Labs Halo image analysis software.Quantitative Digital Pathology | Image Analysis | Visiopharm | Indica Labs HALO | Deep Learning | Artificial Intelligence | Oncology | Immunotherapy | Biomarkers | Multiplex Analysis | Immuohistochemistry | Immunofluorescence | RNAScope |
Listed skills include Biomarkers, Drug Discovery, Immunohistochemistry, Cro, and 21 others.